Back to newsMinerva Imaging strengthen its position as radiopharmaceutical CRO
As announced in the strategic partnership with GE Healthcare, Minerva Imaging will expand its facility in Ølstykke. With the new 1500 square meter GMP compliant facility we strengthen our position as a radiopharmaceutical CRO. We expect to have the cyclotron up and running by the end of 2022, allowing us to produce on-site radioisotopes. Interested in how our capabilities can support your drug development program? Contact us for more information.
Bellow you can follow the construction project. Note: will update this article regularly.
July 2022
The walls of the -1 floor are now completed. We are on track towards a GMP compliant facility for in-house production of isotopes and CDMO services for radiopharmaceuticals early 2023.
April 2022
The expansion of our facility in Ølstykke is on track and last week the concrete walls for the -2 floor were completed. It is great to see the progress so far!
February 2022
Official start of the expansion by Minerva’s co-founders Carsten Nielsen and Andreas Kjaer.
